Patent ID: 8491892

Claim:
Pharmaceutical composition for the treatment of complaints of the gastrointestinal tract, the pharmaceutical composition comprising a particulate active carbon in the form of active carbon particles in the form of active carbon beads or spherules, wherein the active carbon is obtained by carbonization and subsequent activation of styrene/divinylbenzene copolymers, wherein the active carbon has a total pore volume according to Gurvich in the range of from 0.50 to 0.90 cm 3 /g and wherein the active carbon has a micropore volume content formed from pores having pore diameters of ≦25 Å of at least 70%, based on the total pore volume of the active carbon, and wherein the active carbon has an average pore diameter of at most 30 Å, wherein the pharmaceutical composition is present in the form of a perorally administrable administration form, wherein the pharmaceutical composition contains a pharmacologically acceptable excipient and comprises the active carbon in amounts of from 100 mg to 1,000 mg per administrative unit; and wherein the pharmaceutical composition is in a form selected from the group consisting of capsules, tablets, pellets, comprettes and pills.